NASDAQ:CRVO
CervoMed Inc.
CervoMed Inc.'s revenue fell 58.9% in fiscal 2025 to $4.0M while operating margin fell to −706.2%, its lowest in 3 years.Summary generated from CervoMed Inc.'s SEC filings. Latest annual report filed Mar 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$4.0M
Revenue growth−58.9%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−706.2%
Net margin−673.1%
ROICn/a
Return on equity−93.9%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | 0 | 7 | 10 | 4 |
| Operating income | −25 | −3 | −8 | −18 | −28 |
| Net income | −24 | −6 | −2 | −16 | −27 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- 8-KRegulation FD disclosure
Oct 9, 2026 - 8-KRegulation FD disclosure
Sep 28, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KRegulation FD disclosure
Aug 4, 2026 - 8-KRegulation FD disclosure
Jul 14, 2026 - 8-KRegulation FD disclosure
Jul 9, 2026